You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (53)

Journals (0)

1-10 of 53 results for Hedgehog pathway inhibitor

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Hedgehog pathway inhibition in advanced basal cell carcinoma: latest evidence and clinical usefulness

Free access

Review article

First published 2016-9

Hedgehog pathway inhibition in advanced basal cell carcinoma: latest evidence and clinical usefulness

Sirunya Silapunt, Leon Chen, Michael R. Migden

Therapeutic Advances in Medical Oncology

Select article: A Novel and Efficient Route for Synthesis of Taladegib

Free access

Research article

First published 2017-2

A Novel and Efficient Route for Synthesis of Taladegib

Mingliang Guo, Kwon Ho Hong, Yongfeng Lv [...]

Journal of Chemical Research

Select article: Glasdegib plus low-dose cytarabine for acute myeloid leukemia: Practical considerations from advanced practitioners and pharmacists

Open access

Review article

First published 2021-4

Glasdegib plus low-dose cytarabine for acute myeloid leukemia: Practical considerations from advanced practitioners and pharmacists

Valerie Relias, Ali McBride, Matthew J Newman [...]

Journal of Oncology Pharmacy Practice

Select article: Combined cemiplimab and radiotherapy for advanced basal cell carcinoma: A case report

Open access

Case report

First published 2023

Combined cemiplimab and radiotherapy for advanced basal cell carcinoma: A case report

Sidra Sarfaraz, Robert C Hayes, Anne-Marie Hunt

Sage Open Medical Case Reports

Select article: Clinical Prioritization of Adverse Events Associated With Hedgehog Pathway Inhibitors in Basal Cell Carcinoma Patients: Insights From the FDA Adverse Event Reporting (FAERS) System

Retricted access

Letter

First published 2026

Clinical Prioritization of Adverse Events Associated With Hedgehog Pathway Inhibitors in Basal Cell Carcinoma Patients: Insights From the FDA Adverse Event Reporting (FAERS) System

Ze-qun Qiu, Shan-yuan Ye, Run-dong Zhang [...]

Journal of Cutaneous Medicine and Surgery

Select article: Alginate microspheres encapsulating hox transcript antisense RNA siRNA regulate the Hedgehog-Gli1 pathway to alleviate epidermal growth factor receptor tyrosine kinase inhibitors resistance

Retricted access

Research article

First published 2024-3

Alginate microspheres encapsulating hox transcript antisense RNA siRNA regulate the Hedgehog-Gli1 pathway to alleviate epidermal growth factor receptor tyrosine kinase inhibitors resistance

Guojie Lu, Huiling Zhong, Jianwei Gao [...]

Journal of Biomaterials Applications

Select article: A High-Throughput,Homogeneous,Fluorescence Polarization Assay for Inhibitors of Hedgehog Protein Autoprocessing

Free access

Research article

First published 2010-10

A High-Throughput,Homogeneous,Fluorescence Polarization Assay for Inhibitors of Hedgehog Protein Autoprocessing

Shu-qin Jiang, Henry Paulus

Journal of Biomolecular Screening

Select article: An Efficient Synthesis of Erismodegib

Free access

Research article

First published 2014-1

An Efficient Synthesis of Erismodegib

Bing Hu, Jin Cai, Junqing Chen [...]

Journal of Chemical Research

Select article: PTHrP Treatment Fails to Rescue Bone Defects Caused by Hedgehog Pathway Inhibition in Young Mice

Free access

Research article

First published 2011-4

PTHrP Treatment Fails to Rescue Bone Defects Caused by Hedgehog Pathway Inhibition in Young Mice

Jillian L. Brechbiel, Jessica M. Y. Ng, Tom Curran

Toxicologic Pathology

Select article: Brief overview: cemiplimab for the treatment of advanced basal cell carcinoma: PD-1 strikes again

Open access

Review article

First published 2022

Brief overview: cemiplimab for the treatment of advanced basal cell carcinoma: PD-1 strikes again

Christina M. Davis, Karl D. Lewis

Therapeutic Advances in Medical Oncology

1
2
3
•••
6
10 / page

Article type

Publication date

Subjects

Access